---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-135721"
form_type: "8-K"
ticker: "SPRY"
cik: "0001671858"
company_name: "ARS Pharmaceuticals, Inc."
filed_at: "2024-05-10T23:59:59+00:00"
generated_at: "2026-06-02T03:51:51.695288+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ARS Pharmaceuticals updates corporate presentation; no specific new details disclosed

## Summary
- Filed an updated corporate presentation for investor meetings on May 10, 2024.
- Presentation available on company website; no material financial or operational updates provided.
- No earnings, guidance, or pipeline changes mentioned in the filing text or exhibit title.
- Investors should review the full presentation for any potential updates not summarized here.

## SEC filing metadata
- accession: 0001193125-24-135721
- form_type: 8-K
- ticker: SPRY
- cik: 0001671858
- company_name: ARS Pharmaceuticals, Inc.
- filed_at: 2024-05-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671858/000119312524135721/0001193125-24-135721-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671858/000119312524135721/d820291d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-135721
- JSON: https://secwatch.observer/filing/0001193125-24-135721.json
- Plain text: https://secwatch.observer/filing/0001193125-24-135721.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.